Skip to content

EBITDA margin at other companies

ITG
Integer HoldingsITGR
18.3%-0.8pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp
Haemonetics logo
HaemoneticsHAE
27.6%+6.1pp
Abbott logo
AbbottABT
24.1%-0.2pp
Baxter International logo
Baxter InternationalBAX
5.9%-6.2pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
22.1%+0.3pp

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Calculated from LeMaitre Vascular’s reported figures.

Based on trailing twelve months.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's EBITDA margin?
LeMaitre Vascular (LMAT) reported EBITDA margin of 32.6% in Q1 2026.
How has LeMaitre Vascular's EBITDA margin changed year-over-year?
LeMaitre Vascular's EBITDA margin increased by 17.5% year-over-year, from 27.8% to 32.6%.
What is the long-term trend for LeMaitre Vascular's EBITDA margin?
Over 3 years (2022 to 2025), LeMaitre Vascular's EBITDA margin has grown at a 11.8% compound annual growth rate (CAGR), from 22.4% to 31.4%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.